HCV reinfection after HCV therapy among HIV/HCV‐coinfected individuals in Europe-Reference-Cited by-同舟云学术

HCV reinfection after HCV therapy among HIV/HCV‐coinfected individuals in Europe

Published:2021-12-09 Issue: Volume: Page:
ISSN:1464-2662
Container-title:HIV Medicine
language:en
Short-container-title:HIV Med

Author:

Amele Sarah¹,Sandri Anastasia Karachalia²,Rodger Alison¹^ORCID,Vandekerckhove Linos³,Benfield Thomas⁴,Milinkovic Ana⁵,Duvivier Claudine⁶,Stellbrink Hans‐Jürgen⁷,Sambatakou Helen⁸,Chkhartishvili Nikoloz⁹^ORCID,Caldeira Luis¹⁰,Laguno Monserrat¹¹,Domingo Pere¹²^ORCID,Wandeler Gilles¹³,Gisinger Martin¹⁴,Kuzovatova Elena¹⁵,Dragovic Gordana¹⁶,Knysz Brygida¹⁷,Matulionyte Raimonda¹⁸,Rockstroh Jürgen Kurt¹⁹,Lundgren Jens Dilling²,Mocroft Amanda¹²,Peters Lars²,Harxhi A,Losso M,Kundro M,Schmied B,Zangerle R,Karpov I,Vassilenko A,Mitsura VM,Paduto D,Clumeck N,Wit S De,Delforge M,Florence E,Vandekerckhove L,Hadziosmanovic V,Begovac J,Machala L,Jilich D,Sedlacek D,Kronborg G,Benfield T,Gerstoft J,Katzenstein T,Pedersen C,Johansen IS,Ostergaard L,Wiese L,Moller NF,Nielsen L N,Zilmer K,Smidt Jelena,Aho I,Viard J‐P,Girard P‐M,Pradier C,Fontas E,Duvivier C,Rockstroh J,Behrens G,Degen O,Stellbrink HJ,Stefan C,Bogner J,Fätkenheuer G.,Chkhartishvili N,Sambatakou H,Adamis G,Paissios N,Szlávik J,Gottfredsson M,Devitt E,Tau L,Turner D,Burke M,Shahar E,Hassoun G,Elinav H,Haouzi M,Elbirt D,D’Arminio Monforte A,Esposito R,Mazeu I,Mussini C,Mazzotta F,Gabbuti A,Lazzarin A,Castagna A,Gianotti N,Galli M,Ridolfo A,Sacco L.,Uzdaviniene V,Matulionyte R,Staub T,Hemmer R,Dragas S,Stevanovic M,Reiss P,Trajanovska J,Reikvam DH,Maeland A,Bruun J,Knysz B,Gasiorowski J,Inglot M,Bakowska E,Flisiak R,Grzeszczuk A,Parczewski M,Maciejewska K,Aksak‐Was B,Beniowski M,Mularska E,Jablonowska E,Kamerys J,Wojcik K,Mozer‐Lisewska I,Rozplochowski B,Zagalo A,Mansinho K,Maltez F,Radoi R,Oprea C,Davila Carol,Yakovlev A,Trofimora T,Khromova I,Kuzovatova E,Blokhina I.N.,Novogrod Nizhny,Borodulina E,Vdoushkina E,Ranin J,Tomazic J,Miro JM,Miró JM,Martinez E,Garcia F,Blanco JL,Martinez‐Rebollar M,Mallolas J,Callau P,Rojas J,Inciarta A,Moreno S,del Campo S.,Clotet B,Jou A,Paredes R,Puig J,Llibre JM,Santos JR,Domingo P,Gutierrez M,Mateo G,Sambeat MA,Laporte JM,Falconer K,Thalme A,Sonnerborg A,Brannstrom J,Flamholc L,Scherrer A,Weber R,Cavassini M,Calmy A,Furrer H,Battegay M,Schmid P,Kuznetsova A,Mikhalik J,Sluzhynska M,Milinkovic A,Johnson AM,Simons E,Edwards S,Phillips A,Johnson, MA,Mocroft A,Orkin C,Winston A,Clarke A,Leen C,Karpov I,Losso M,Lundgren J,Rockstroh J,Aho I,Rasmussen LD,Svedhem V,Wandeler G,Pradier C,Chkhartishvili N,Matulionyte R,Oprea C,Kowalska JD,Begovac J,Miró JM,Guaraldi G,Paredes R,Wandeler G,Paredes R,Peters L,Kirk O,Peters L,Bojesen A,Raben D,Hansen EV,Kristensen D,Larsen JF,Fischer AH,Mocroft A,Phillips A,Cozzi‐Lepri A,Amele S,Pelchen‐Matthews A,Roen A,Tusch E,Bannister W,Reekie J,

Affiliation:

1. Centre for Clinical Research Epidemiology, Modelling and Evaluation Institute for Global Health University College London London UK

2. CHIP, Rigshospitalet Copenhagen Denmark

3. Ghent University Hospital Ghent Belgium

4. Copenhagen University Hospital – Amager and Hvidovre Hvidovre Denmark

5. Chelsea and Westminster Hospital London UK

6. AP‐HP ‐ Necker Enfants Malades HospitalInfectious Diseases Department; Necker Pasteur Center for Infectious Diseases and Tropical Medicine; Université de Paris; IHU Imagine Paris France

7. ICH Study Center Hamburg Germany

8. Ippokration General Hospital Athens Greece

9. Infectious Diseases AIDS & Clinical Immunology Research Center Tbilisi Georgia

10. Santa Maria University HospitalUniversity of Lisbon Lisbon Portugal

11. Infectious Diseases Service Hospital Clinic Barcelona Spain

12. Hospital de la Santa Creu i Sant Pau Barcelona Spain

13. Department of Infectious Diseases Bern University HospitalUniversity of Bern Bern Switzerland

14. Medical University of Innsbruck Innsbruck Austria

15. Nizhny Novgorod Scientific and Research Institute Nizhny Novgorod Russia

16. Department of Pharmacology Clinical Pharmacology and Toxicology School of Medicine University of Belgrade Belgrade Serbia

17. Wroclaw Medical University Wroclaw Poland

18. Department of Infectious Diseases and Dermatovenerology Faculty of Medicine Vilnius University; Vilnius University Hospital Santaros Klinikos Vilnius Lithuania

19. Universitäts Klinik Bonn Bonn Germany

Funder

Seventh Framework Programme

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Publisher

Wiley

Subject

Pharmacology (medical),Infectious Diseases,Health Policy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hiv.13212

Reference15 articles.

1. Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection

2. Accessed July 2 2021.https://apps.who.int/iris/bitstream/handle/10665/206453/WHO_HIV_2016.04_eng.pdf;jsessionid=D4568E7F1B7FB3E11532F729CCBB35E9?sequence=1. In: 2021.

3. Long-Term Treatment Outcomes of Patients Infected With Hepatitis C Virus: A Systematic Review and Meta-analysis of the Survival Benefit of Achieving a Sustained Virological Response

4. Reinfection With the Hepatitis C Virus in Men Who Have Sex With Men After Successful Treatment With Direct-acting Antivirals in Germany: Current Incidence Rates, Compared With Rates During the Interferon Era

5. Reinfection by hepatitis C virus following effective all-oral direct-acting antiviral drug therapy in HIV/hepatitis C virus coinfected individuals

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIV Care in Ukrainian Migrants in Two European Countries: All the Same?;Pathogens;2024-07-26

2. Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010–19: an analysis of data from a consortium of prospective cohort studies;The Lancet HIV;2024-02

3. Effectiveness of hepatitis C antiviral treatment and feasibility of hepatitis C elimination goal;Postgraduate Medicine;2022-11-04

4. Gamma-Delta T-Cell Phenotype and Function in DAA-Treated HIV-HCV Co-Infected and HCV-Mono-Infected Subjects;Viruses;2022-07-22

5. Hepatitis C Virus Reinfection in People With HIV in Taiwan After Achieving Sustained Virologic Response With Antiviral Treatment: The RECUR Study;Open Forum Infectious Diseases;2022-07-22